Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | USP30 | Q70CQ3 | 6/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | UCHL1 | P09936 | 3/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1257155 | 0.99 | HSD17B10 (0.49) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL1250737 | 0.99 | HSD17B10 (0.49) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL5328715 | 0.99 | HSD17B10 (0.49) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL25395953 | 0.94 | HSD17B10 (0.53) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL1584759 | 0.94 | HSD17B10 (0.53) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL903492 | 0.94 | HSD17B10 (0.53) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL1256351 | 0.94 | HSD17B10 (0.53) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL2096289 | 0.89 | HSD17B10 (0.43) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL444365 | 0.89 | HSD17B10 (0.43) | HSD17B10USP30SMN1; SMN2NPC1LMNA | |
| SCHEMBL25701906 | 0.89 | HSD17B10 (0.43) | HSD17B10USP30SMN1; SMN2NPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024178304-A1 | KRAS MODULATORS | ALTEROME THERAPEUTICS, INC. (US) | 2024-08-29 | — | — | WO | disclosed |